Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Adverse Events Related to Treatment and Quality of Life Outcomes in Patients with Mucosal Head and Neck Squamous Cell Carcinoma Undergoing Immune Checkpoint Inhibitor Therapy: A Scoping Review

  • By

  • N. D. O'Donnell

  • E. C. Ward

  • L. R. Wishart

  • R. Perera

  • C. Barrett

  • K. A. Edmiston

  • E. Mitchell

  • A. Pigott

  • R. Pitt

  • K. Russell

  • B. A. Chan

  • R. Ladwa

  • June 1, 2026

Share

Original Source(s)

Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

  • by N. D. O'Donnell, E. C. Ward, L. R. Wishart, R. Perera, C. Barrett, K. A. Edmiston, E. Mitchell, A. Pigott, R. Pitt, K. Russell, B. A. Chan, R. Ladwa

  • June 1, 2026

Related Content

Efficiency and Sustainability in the Skin Cancer Excision Pathway: Life Cycle Assessment and Process Map

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

Submental Approach Robotic-Assisted Neck Dissection (SARAND) for Minimally Invasive Bilateral Neck Dissection: A Feasibility Cadaver Dissection Study